167 related articles for article (PubMed ID: 20577872)
21. Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis.
McClung MR; Lippuner K; Brandi ML; Zanchetta JR; Bone HG; Chapurlat R; Hans D; Wang A; Zapalowski C; Libanati C
Osteoporos Int; 2017 Oct; 28(10):2967-2973. PubMed ID: 28748386
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of computed digital absorptiometry and conventional dual-energy X-ray absorptiometry in postmenopausal women.
Fiter J; Nolla JM; Gómez-Vaquero C; Martínez-Aguilá D; Valverde J; Roig-Escofet D
Osteoporos Int; 2001; 12(7):565-9. PubMed ID: 11527054
[TBL] [Abstract][Full Text] [Related]
23. Current role for bone absorptiometry.
Roux C; Briot K
Joint Bone Spine; 2017 Jan; 84(1):35-37. PubMed ID: 27282091
[TBL] [Abstract][Full Text] [Related]
24. New method for point-of-care osteoporosis screening and diagnostics.
Karjalainen JP; Riekkinen O; Töyräs J; Jurvelin JS; Kröger H
Osteoporos Int; 2016 Mar; 27(3):971-977. PubMed ID: 26556741
[TBL] [Abstract][Full Text] [Related]
25. Racial disparity in treatment of osteoporosis after diagnosis.
Hamrick I; Whetstone LM; Cummings DM
Osteoporos Int; 2006; 17(11):1653-8. PubMed ID: 16871433
[TBL] [Abstract][Full Text] [Related]
26. Revised FRAX®-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka.
Lekamwasam S; Chandran M; Subasinghe S
Arch Osteoporos; 2019 Mar; 14(1):33. PubMed ID: 30850909
[TBL] [Abstract][Full Text] [Related]
27. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
[TBL] [Abstract][Full Text] [Related]
28. A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis.
Williams ST; Lawrence PT; Miller KL; Crook JL; LaFleur J; Cannon GW; Nelson RE
Osteoporos Int; 2017 Nov; 28(11):3107-3111. PubMed ID: 28756457
[TBL] [Abstract][Full Text] [Related]
29. Which is the preferred site for bone mineral density monitoring as an indicator of treatment-related anti-fracture effect in routine clinical practice? A registry-based cohort study.
Leslie WD; Martineau P; Bryanton M; Lix LM
Osteoporos Int; 2019 Jul; 30(7):1445-1453. PubMed ID: 31016351
[TBL] [Abstract][Full Text] [Related]
30. Prediction of hip osteoporosis by DXA using a novel pulse-echo ultrasound device.
Schousboe JT; Riekkinen O; Karjalainen J
Osteoporos Int; 2017 Jan; 28(1):85-93. PubMed ID: 27492435
[TBL] [Abstract][Full Text] [Related]
31. Cost effectiveness of ultrasound and bone densitometry for osteoporosis screening in post-menopausal women.
Mueller D; Gandjour A
Appl Health Econ Health Policy; 2008; 6(2-3):113-35. PubMed ID: 19231905
[TBL] [Abstract][Full Text] [Related]
32. Socioeconomic status and risk of osteoporotic fractures and the use of DXA scans: data from the Danish population-based ROSE study.
Holmberg T; Möller S; Rothmann MJ; Gram J; Herman AP; Brixen K; Tolstrup JS; Høiberg M; Bech M; Rubin KH
Osteoporos Int; 2019 Feb; 30(2):343-353. PubMed ID: 30465216
[TBL] [Abstract][Full Text] [Related]
33. Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing.
Cadarette SM; Gignac MA; Jaglal SB; Beaton DE; Hawker GA
Med Care; 2007 Sep; 45(9):896-901. PubMed ID: 17712261
[TBL] [Abstract][Full Text] [Related]
34. Automated DXA-based finite element analysis for hip fracture risk stratification: a cross-sectional study.
Yang S; Leslie WD; Luo Y; Goertzen AL; Ahmed S; Ward LM; Delubac I; Lix LM
Osteoporos Int; 2018 Jan; 29(1):191-200. PubMed ID: 29038836
[TBL] [Abstract][Full Text] [Related]
35. Comparison of plain vertebral X-ray and dual-energy X-ray absorptiometry for the identification of older women for fracture prevention in primary care.
Robinson PJ; Bell RJ; Lanzafame A; Segal L; Kirby C; Piterman L; Davis SR
Intern Med J; 2013 Jan; 43(1):38-45. PubMed ID: 22931254
[TBL] [Abstract][Full Text] [Related]
36. Bone health-related factors and the use of bisphosphonates in community setting--15-year follow-up study.
Sirola J; Salovaara K; Rikkonen T; Kärkkäinen M; Tuppurainen M; Jurvelin JS; Honkanen R; Kröger H
Osteoporos Int; 2011 Jan; 22(1):255-64. PubMed ID: 20422155
[TBL] [Abstract][Full Text] [Related]
37. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
38. Assessment of osteoporosis: comparison of radiographic absorptiometry of the phalanges and dual X-ray absorptiometry of the radius and lumbar spine.
Takada M; Engelke K; Hagiwara S; Grampp S; Jergas M; Glüer CC; Genant HK
Radiology; 1997 Mar; 202(3):759-63. PubMed ID: 9051031
[TBL] [Abstract][Full Text] [Related]
39. Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
Osteoporos Int; 2017 Aug; 28(8):2485-2494. PubMed ID: 28536737
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of overtreatment of osteoporosis: results from the PAADRN trial.
Hall SF; Wright NC; Wolinsky FD; Lou Y; Edmonds S; Roblin D; Jones M; Saag K; Cram P
Arch Osteoporos; 2018 Sep; 13(1):103. PubMed ID: 30267162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
